Literature DB >> 23913724

Depletion of HPV16 early genes induces autophagy and senescence in a cervical carcinogenesis model, regardless of viral physical state.

Jennifer E Hanning1, Harpreet K Saini, Matthew J Murray, Maria M Caffarel, Stijn van Dongen, Dawn Ward, Emily M Barker, Cinzia G Scarpini, Ian J Groves, Margaret A Stanley, Anton J Enright, Mark R Pett, Nicholas Coleman.   

Abstract

In cervical carcinomas, high-risk human papillomavirus (HR-HPV) may be integrated into host chromosomes or remain extra-chromosomal (episomal). We used the W12 cervical keratinocyte model to investigate the effects of HPV16 early gene depletion on in vitro cervical carcinogenesis pathways, particularly effects shared by cells with episomal versus integrated HPV16 DNA. Importantly, we were able to study the specific cellular consequences of viral gene depletion by using short interfering RNAs known not to cause phenotypic or transcriptional off-target effects in keratinocytes. We found that while cervical neoplastic progression in vitro was characterized by dynamic changes in HPV16 transcript levels, viral early gene expression was required for cell survival at all stages of carcinogenesis, regardless of viral physical state, levels of early gene expression or histology in organotypic tissue culture. Moreover, HPV16 early gene depletion induced changes in host gene expression that were common to both episome-containing and integrant-containing cells. In particular, we observed up-regulation of autophagy genes, associated with enrichment of senescence and innate immune-response pathways, including the senescence-associated secretory phenotype (SASP). In keeping with these observations, HPV16 early gene depletion induced autophagy in both episome-containing and integrant-containing W12 cells, as evidenced by the appearance of autophagosomes, punctate expression of the autophagy marker LC3, conversion of LC3B-I to LC3B-II, and reduced levels of the autophagy substrate p62. Consistent with the reported association between autophagy and senescence pathways, HPV16 early gene depletion induced expression of the senescence marker beta-galactosidase and increased secretion of the SASP-related protein IGFBP3. Together, these data indicate that depleting HR-HPV early genes would be of potential therapeutic benefit in all cervical carcinogenesis pathways, regardless of viral physical state. In addition, the senescence/SASP response associated with autophagy induction may promote beneficial immune effects in bystander cells.
Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Keywords:  HPV16; autophagy; cervix; senescence; squamous cell carcinoma

Mesh:

Substances:

Year:  2013        PMID: 23913724     DOI: 10.1002/path.4244

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  18 in total

1.  Topical application of a dual PI3K/mTOR inhibitor prevents anal carcinogenesis in a human papillomavirus mouse model of anal cancer.

Authors:  Brooks L Rademacher; Kristina A Matkowskyj; Emily D LaCount; Evie H Carchman
Journal:  Eur J Cancer Prev       Date:  2019-11       Impact factor: 2.497

2.  Human Papillomavirus 11 Early Protein E6 Activates Autophagy by Repressing AKT/mTOR and Erk/mTOR.

Authors:  Boya Zhang; Yinjing Song; Siyuan Sun; Rui Han; Chunting Hua; Stijn van der Veen; Hao Cheng
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

Review 3.  Autophagy knocked down by high-risk HPV infection and uterine cervical carcinogenesis.

Authors:  Xueli Li; Zhengyuan Gong; Linglin Zhang; Chen Zhao; Xianda Zhao; Xin Gu; Honglei Chen
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 4.  Autophagy in malignant transformation and cancer progression.

Authors:  Lorenzo Galluzzi; Federico Pietrocola; José Manuel Bravo-San Pedro; Ravi K Amaravadi; Eric H Baehrecke; Francesco Cecconi; Patrice Codogno; Jayanta Debnath; David A Gewirtz; Vassiliki Karantza; Alec Kimmelman; Sharad Kumar; Beth Levine; Maria Chiara Maiuri; Seamus J Martin; Josef Penninger; Mauro Piacentini; David C Rubinsztein; Hans-Uwe Simon; Anne Simonsen; Andrew M Thorburn; Guillermo Velasco; Kevin M Ryan; Guido Kroemer
Journal:  EMBO J       Date:  2015-02-23       Impact factor: 11.598

5.  Short- and long-range cis interactions between integrated HPV genomes and cellular chromatin dysregulate host gene expression in early cervical carcinogenesis.

Authors:  Ian J Groves; Emma L A Drane; Marco Michalski; Jack M Monahan; Cinzia G Scarpini; Stephen P Smith; Giovanni Bussotti; Csilla Várnai; Stefan Schoenfelder; Peter Fraser; Anton J Enright; Nicholas Coleman
Journal:  PLoS Pathog       Date:  2021-08-25       Impact factor: 6.823

6.  The role of pharmacologic modulation of autophagy on anal cancer development in an HPV mouse model of carcinogenesis.

Authors:  Brooks L Rademacher; Kristina A Matkowskyj; Louise M Meske; Alexis Romero; Hana Sleiman; Evie H Carchman
Journal:  Virology       Date:  2017-04-18       Impact factor: 3.616

7.  Re-expression of HPV16 E2 in SiHa (human cervical cancer) cells potentiates NF-κB activation induced by TNF-α concurrently increasing senescence and survival.

Authors:  Devan Prabhavathy; Chandrasekaran Karthik Subramanian; Devarajan Karunagaran
Journal:  Biosci Rep       Date:  2015-02-25       Impact factor: 3.840

8.  HPV16 E5 deregulates the autophagic process in human keratinocytes.

Authors:  Francesca Belleudi; Monica Nanni; Salvatore Raffa; Maria Rosaria Torrisi
Journal:  Oncotarget       Date:  2015-04-20

9.  Identification of host transcriptional networks showing concentration-dependent regulation by HPV16 E6 and E7 proteins in basal cervical squamous epithelial cells.

Authors:  Stephen P Smith; Cinzia G Scarpini; Ian J Groves; Richard I Odle; Nicholas Coleman
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

10.  HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome.

Authors:  I J Groves; E L A Knight; Q Y Ang; C G Scarpini; N Coleman
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.